AKT1 and nasopharyngeal carcinoma: Our results are also consistent with those of a previous study in which miR-155 transfection in human nasopharyngeal cancer and human cervical cancer cells inhibited several components of PI3K-Akt-mTOR signaling, including RHEB, RICTOR, phosphorylated mTOR and Akt [91].